Balyasny Asset Management LLC Vertex Pharmaceuticals Inc Transaction History

Balyasny Asset Management LLC

$58 Billion
Q3 2024

A detailed history of Balyasny Asset Management LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Balyasny Asset Management LLC holds 500 shares of VRTX stock, worth $198,635. This represents 0.0% of its overall portfolio holdings.

Number of Shares

500

Previous 900 44.44%

Holding current value

$198,635

Previous $421,000 44.89%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$460.0 - $505.78 $24 Million - $26.4 Million	52,180 Added 2276.61%	54,472 $25.3 Million
Q2 2024 Aug 14, 2024	SELL	$392.81 - $485.53 $73 Million - $90.2 Million	-185,844 Reduced 98.78%	2,292 $1.07 Million
Q1 2024 May 13, 2024	BUY	$407.69 - $446.08 $74.8 Million - $81.8 Million	183,380 Added 3855.76%	188,136 $78.6 Million
Q4 2023 Feb 14, 2024	BUY	$343.0 - $410.68 $299,439 - $358,523	873 Added 22.48%	4,756 $1.94 Million
Q3 2023 Nov 14, 2023	BUY	$338.18 - $362.46 $53,770 - $57,631	159 Added 4.27%	3,883 $1.35 Million
Q2 2023 Aug 14, 2023	SELL	$314.42 - $351.91 $11.1 Million - $12.4 Million	-35,245 Reduced 90.44%	3,724 $1.31 Million
Q1 2023 May 15, 2023	BUY	$283.23 - $323.1 $325,148 - $370,918	1,148 Added 3.04%	38,969 $12.3 Million
Q4 2022 Feb 14, 2023	BUY	$285.76 - $321.48 $10.8 Million - $12.2 Million	37,821 New	37,821 $10.9 Million
Q1 2022 May 16, 2022	SELL	$221.42 - $260.97 $42.5 Million - $50.1 Million	-192,035 Reduced 90.86%	19,312 $5.04 Million
Q4 2021 Feb 14, 2022	BUY	$177.01 - $223.45 $10 Million - $12.7 Million	56,709 Added 36.67%	211,347 $46.4 Million
Q3 2021 Nov 15, 2021	BUY	$181.39 - $202.99 $28 Million - $31.4 Million	154,638 New	154,638 $28.1 Million
Q3 2020 Nov 16, 2020	SELL	$255.65 - $303.1 $1.09 Million - $1.29 Million	-4,249 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$225.48 - $295.8 $958,064 - $1.26 Million	4,249 New	4,249 $1.23 Million
Q1 2020 May 15, 2020	SELL	$199.77 - $247.81 $31.8 Million - $39.5 Million	-159,396 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$166.71 - $223.91 $25.7 Million - $34.6 Million	154,353 Added 3060.74%	159,396 $34.9 Million
Q2 2019 Aug 14, 2019	SELL	$164.61 - $190.37 $2.41 Million - $2.79 Million	-14,660 Reduced 74.4%	5,043 $925,000
Q1 2019 May 15, 2019	SELL	$163.73 - $194.7 $274,247 - $326,122	-1,675 Reduced 7.84%	19,703 $3.62 Million
Q4 2018 Feb 14, 2019	BUY	$151.91 - $192.21 $816,212 - $1.03 Million	5,373 Added 33.57%	21,378 $3.54 Million
Q3 2018 Nov 14, 2018	BUY	$167.73 - $192.74 $2.68 Million - $3.08 Million	16,005 New	16,005 $3.09 Million
Q1 2018 May 15, 2018	SELL	$151.6 - $177.13 $52.7 Million - $61.5 Million	-347,312 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$137.28 - $155.55 $21.4 Million - $24.2 Million	155,682 Added 81.24%	347,312 $52 Million
Q3 2017 Nov 14, 2017	BUY	$148.13 - $162.24 $28.4 Million - $31.1 Million	191,630	191,630 $29.1 Million

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

221M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $102B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Account

Balyasny Asset Management LLC Vertex Pharmaceuticals Inc Transaction History